tirzepatide .25 5mg Lilly Q3'25: Ranks First in
Description
Semaglutide for Obesity (NEJM, 2025) Rodriguez et al
Retatrutide shows superior fat loss in trials up to 24% total body weight vs 21% with Tirzepatide
By activating two gut hormone pathways, it helps your body release insulin when blood sugar is high, slows how quickly the stomach empties, and reduces appetite
Tirzepatide is a once-weekly injectable medication, FDA-approved under the brand name Mounjaro to treat type 2 diabetes and FDA-approved under the brand name Zepbound for weight loss
From a smooth and straightforward consultation process to regularly checking in to monitor progress, we are here to help
